Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00985595 · ClinicalTrials.gov registry record
Learning Effective Approaches to Prevention
A clinical trial, sponsored by The National Center on Addiction and Substance Abuse at Columbia University.
- Completed
- Registry status
- 200
- Enrollment target
NCT00985595: Completed study, sponsored by The National Center on Addiction and Substance Abuse at Columbia University.
NCT00985595 is a clinical trial that has completed, run by The National Center on Addiction and Substance Abuse at Columbia University. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00985595 has completed, sponsored by The National Center on Addiction and Substance Abuse at Columbia University.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The objective of the study is to test the effectiveness, implementation quality, and cost effectiveness of family-based treatment services for adolescent substance abuse delivered in an agency setting.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-01 |
| Est. Completion | 2012-03 |
What the finished NCT00985595 record still lists
NCT00985595 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00985595 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00985595 about?
NCT00985595 is a clinical study titled "Learning Effective Approaches to Prevention". The objective of the study is to test the effectiveness, implementation quality, and cost effectiveness of family-based treatment services for adolescent substance abuse delivered in an agency setting.
What is the current status of trial NCT00985595?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2006-01. Estimated completion is 2012-03.
Who is sponsoring clinical trial NCT00985595?
This trial is sponsored by The National Center on Addiction and Substance Abuse at Columbia University, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia